中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
13期
42-44
,共3页
慢性肛裂%肛门后正中切扩术%肛门内括约肌侧切术
慢性肛裂%肛門後正中切擴術%肛門內括約肌側切術
만성항렬%항문후정중절확술%항문내괄약기측절술
Chronic anal fissure%Posterior medial internal sphincterotomy%Lateral internal sphincterotomy
目的：探讨两种手术方法治疗慢性肛裂的临床疗效。方法选取2012年7月~2014年6月本院收治的305例慢性肛裂患者随机分为切扩术组(153例)给予肛门后正中原位切扩术治疗，侧切术组(152例)给予肛门扩<肌侧切术治疗。观察两组的总治愈率、术后愈合天数及术后复发率。结果切扩术组总治愈率为94%，侧切术组总治愈率为72%；切扩术组和侧切术组术后创面愈合平均天数分别为(14±0.9)、(10±0.8) d；术后随访3个月复发率，切扩术组复发率1.3%(2例)，侧切术组复发率3.9%(6例)，两组比较，差异有统计学意义(P<0.05)。结论切扩术治疗慢性肛裂优于侧切术，可成为首选治疗慢性肛裂的手术方式，值得临床推广。
目的：探討兩種手術方法治療慢性肛裂的臨床療效。方法選取2012年7月~2014年6月本院收治的305例慢性肛裂患者隨機分為切擴術組(153例)給予肛門後正中原位切擴術治療，側切術組(152例)給予肛門擴<肌側切術治療。觀察兩組的總治愈率、術後愈閤天數及術後複髮率。結果切擴術組總治愈率為94%，側切術組總治愈率為72%；切擴術組和側切術組術後創麵愈閤平均天數分彆為(14±0.9)、(10±0.8) d；術後隨訪3箇月複髮率，切擴術組複髮率1.3%(2例)，側切術組複髮率3.9%(6例)，兩組比較，差異有統計學意義(P<0.05)。結論切擴術治療慢性肛裂優于側切術，可成為首選治療慢性肛裂的手術方式，值得臨床推廣。
목적：탐토량충수술방법치료만성항렬적림상료효。방법선취2012년7월~2014년6월본원수치적305례만성항렬환자수궤분위절확술조(153례)급여항문후정중원위절확술치료，측절술조(152례)급여항문확<기측절술치료。관찰량조적총치유솔、술후유합천수급술후복발솔。결과절확술조총치유솔위94%，측절술조총치유솔위72%；절확술조화측절술조술후창면유합평균천수분별위(14±0.9)、(10±0.8) d；술후수방3개월복발솔，절확술조복발솔1.3%(2례)，측절술조복발솔3.9%(6례)，량조비교，차이유통계학의의(P<0.05)。결론절확술치료만성항렬우우측절술，가성위수선치료만성항렬적수술방식，치득림상추엄。
Objective To explore the clinical effect of two kinds of operations for treatment of chronic anal fissure. Methods 305 patients with chronic anal fissure in our hospital from July 2012 to June 2014 were selected and ran-domly divided into two groups,posterior-cutting group (n=153),which posterior medial internal sphincterotomy was per-formed,and side-cutting group(n=152),which lateral internal sphincterotomy was performed.Total healing rate,postopera-tive healing time,postoperative recurrence rate between two groups was observed respectively. Results The healing rate was 94%,72%,average wound healing days was (14±0.9), (10±0.8) d,postoperative recurrence rate in three months was 1.3%,3.9%,between posterior-cutting group and side-cutting group respectively,with significant difference (P<0.05). Conclusion The posterior medial internal sphincterotomy is superior to lateral internal sphincterotomy,and can become the first choice of treatment for chronic anal fissure, and worth of clinical application.
